d’Alessandro, M.; Bergantini, L.; Cavallaro, D.; Gangi, S.; Cameli, P.; Conticini, E.; Siena COVID Unit; Frediani, B.; Dotta, F.; Bargagli, E.
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. Int. J. Environ. Res. Public Health 2022, 19, 2176.
https://doi.org/10.3390/ijerph19042176
AMA Style
d’Alessandro M, Bergantini L, Cavallaro D, Gangi S, Cameli P, Conticini E, Siena COVID Unit, Frediani B, Dotta F, Bargagli E.
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. International Journal of Environmental Research and Public Health. 2022; 19(4):2176.
https://doi.org/10.3390/ijerph19042176
Chicago/Turabian Style
d’Alessandro, Miriana, Laura Bergantini, Dalila Cavallaro, Sara Gangi, Paolo Cameli, Edoardo Conticini, Siena COVID Unit, Bruno Frediani, Francesco Dotta, and Elena Bargagli.
2022. "Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II" International Journal of Environmental Research and Public Health 19, no. 4: 2176.
https://doi.org/10.3390/ijerph19042176
APA Style
d’Alessandro, M., Bergantini, L., Cavallaro, D., Gangi, S., Cameli, P., Conticini, E., Siena COVID Unit, Frediani, B., Dotta, F., & Bargagli, E.
(2022). Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. International Journal of Environmental Research and Public Health, 19(4), 2176.
https://doi.org/10.3390/ijerph19042176